FDA 510(k) FDA class 1 Substantially Equivalent 🇺🇸 United States

MODIFICATION TO SERAQUEST VCA IGM

K Number: K033780 · Decision Jan 15, 2004
Classifications
1
FEI Numbers
8
Registration Numbers
8
Same Product Code
22
Applicant Total
25
Review Days
42

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
MODIFICATION TO SERAQUEST VCA IGM
K Number
K033780
Device Class
FDA class 1
Clearance Type
Special
Regulation Number
866.3235
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Quest Intl., Inc.
Date Received
December 4, 2003
Decision Date
January 15, 2004
Product Code
LJN
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LJN Antibody Igm, If, Epstein-Barr Virus

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (LJN), ordered by most recent decision date.

View all

Other Clearances by Quest Intl., Inc.

K Number Device Name
K091260 SERAQUEST EBV EA-D IGG TEST
K033915 MODIFICATION TO SERAQUEST EB VCA IGG
K023593 SERAQUEST ANTI-THYROID PEROXIDASE (TPO)
K023592 SERAQUEST ANTI-THYROGLOBULIN
K003069 ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEM
K991975 SERAQUEST EB NA IGG
K990410 SERAQUEST EB VCA IGG
K990977 SERAQUEST EB VAC IGM
K982485 SERAQUEST CMV IGM
K982281 SERAQUEST RUBELLA IGM
Search all 25 clearances from Quest Intl., Inc. →